Gérard Sanderink

Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.

F Marre, Gérard Sanderink, Georges de Sousa et al. · PubMed · 1996 · 224 citations

Medicine, Pharmacokinetics, Pharmacology +17

Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes

Richard C. Becker, Frederick A. Spencer, Michael Gibson et al. · American Heart Journal · 2002 · 166 citations

Medicine, Cardiology, Pharmacology +14

Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P‐glycoprotein at the blood–brain barrier in mice and rats

Salvatore Cisternino, Fanchon Bourasset, Yves Archimbaud et al. · British Journal of Pharmacology · 2003 · 112 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Pharmacokinetics and metabolism of Taxotere (docetaxel).

René Bruno, Gérard Sanderink · PubMed · 1993 · 85 citations

Medicine, Pharmacokinetics, Pharmacology +15

Reversibility of the anti‐FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion

Isabelle Paty, Marc Trellu, J.M. Destors et al. · Journal of Thrombosis and Haemostasis · 2010 · 60 citations

Medicine, Pharmaceutics, Pharmacology +6